Advanced search
Publication Cover
Emerging Microbes & Infections Volume 4, 2015 - Issue 1
Submit an article Journal homepage
1,151
Views
32
CrossRef citations to date
0
Altmetric
Original Articles

Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case–control design

Shan-Shan ZhenKey Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai200032, ChinaCorrespondence[email protected]
,
Yue LiKey Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai200032, ChinaCorrespondence[email protected]
,
Song-Mei WangLaboratory of Molecular Biology, Training Center of Medical Experiments, School of Basic Medical Sciences, Fudan University, Shanghai200032, ChinaCorrespondence[email protected]
,
Xin-Jiang ZhangZhengding County Center for Disease Control and Prevention, Zhengding050800, Hebei Province, ChinaCorrespondence[email protected]
,
Zhi-Yong HaoZhengding County Center for Disease Control and Prevention, Zhengding050800, Hebei Province, ChinaCorrespondence[email protected]
,
Ying ChenKey Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai200032, China
,
Dan WangKey Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai200032, China
,
Yan-Hong ZhangZhengding County Center for Disease Control and Prevention, Zhengding050800, Hebei Province, China
,
Zhi-Yong ZhangZhengding County Center for Disease Control and Prevention, Zhengding050800, Hebei Province, China
,
Jing-Chen MaHebei Province Center for Disease Control and Prevention, Shijiazhuang050800, Hebei Province, China
,
Peng ZhouKey Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai200032, China
,
Zhen ZhangKey Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai200032, China
,
Zhi-Wei JiangDepartment of Health Statistics, Fourth Military Medical University, Xi’an710032, Shanxi Province, China
,
Yu-Liang ZhaoHebei Province Center for Disease Control and Prevention, Shijiazhuang050800, Hebei Province, ChinaCorrespondence[email protected]
&
Xuan-Yi WangKey Laboratory Medical Molecular Virology, MoE/MoH, and the Institutes of Biomedical Sciences, Shanghai Medical College, Fudan University, Shanghai200032, ChinaCorrespondence[email protected]
 show all
Pages 1-6 | Received 29 Jul 2015, Accepted 09 Sep 2015, Published online: 25 Jan 2019

  • Wang XY, Du L, Von Seidlein L et al.Occurrence of shigellosis in the young and elderly in rural China: results of a 12-month population-based surveillance study. Am J Trop Med Hyg 2005;73: 416–422.
  • Yu WL. [Survey on the prevention and treatment of diarrhoea in part of regions, China.] Zhonghua Liu Xing Bing Xue Za Zhi 1989;10: 257–260.Chinese.
  • Liu N, Xu Z, Li D et al.Update on the disease burden and circulating strains of rotavirus in China: a systematic review and meta-analysis. Vaccine 2014;32: 4369–4375.
  • Wang XY, Riewpaiboon A, von Seidlein L et al.The potential cost-effectiveness of a rotavirus immunization program in rural China. Clin Infect Dis 2009;49: 1202–1210.
  • Wang XY, Xu ZY, von Seidlein L et al.Incidence of diarrhea caused by rotavirus infections in rural Zhengding, China: prospective, population-based surveillance. J Infect Dis 2005;192: S100–105.
  • Rotavirus vaccines.WHO position paper – January 2013. Wkly Epidemiol Rec 2013;88: 49–64.
  • Parashar UD, Bresee JS, Gentsch JR et al.Rotavirus. Emerg Infect Dis 1998;4: 561–570.
  • Fang ZY, Wang B, Kilgore PE et al.Sentinel hospital surveillance for rotavirus diarrhea in the People’s Republic of China, August 2001–July 2003. J Infect Dis 2005;192: s94–99.
  • Orenstein EW, Fang ZY, Xu J et al.The epidemiology and burden of rotavirus in China: a review of the literature from 1983 to 2005. Vaccine 2007;25: 406–413.
  • Sun LW, Tong ZL, Li LH et al. [Surveillance finding on rotavirus in Changchun children’s hospital during July 1998–June 2001.] Zhong Hua Liu Xing Bing Xue Za Zhi 2003;24: 1010–1012.Chinese.
  • Tong ZL, Ma L, Zhang J et al. [Epidemiological study of rotavirus diarrhea in Beijing, China: a hospital-based surveillance from 1998–2001.] Zhong Hua Liu Xing Bing Xue Za Zhi 2003;24:1100–1103.Chinese.
  • Cunliffe NA, Bresee JS, Hart CA.Rotavirus vaccines: development, current issues and future prospects. J Infect 2002;45: 1–9.
  • World Health Organization. Report of the meeting on future directions for rotavirus vaccine research in developing countries.Geneva: WHO, 2000.Available at http://www.who.int/iris/handle/10665/66497 (accessed 6 September 2015).
  • Fu C, He Q, Xu J et al.Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children. Vaccine 2012;31: 154–158.
  • Fu C, Tate JE, Jiang B.Effectiveness of Lanzhou lamb rotavirus vaccine against hospitalized gastroenteritis: further analysis and update. Hum Vaccine 2010;6: 953.
  • Fu C, Wang M, Liang J et al.Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Vaccine 2007;25: 8756–8761.
  • Clemens JD, Kotloff KL, Kay B. Generic protocol to estimate the burden of Shigella diarrhoea and dysenteric mortality.Geneva: WHO, 1999.Available at http://www.who.int/iris/handle/10665/66151 (accessed 6 September 2015).
  • World Health Organization.Generic protocols (i) hospital-based surveillance to estimate the burden of rotavirus gastroenteritis in children and (ii) a community-based survey on utilization of health care services for gastroenteritis in children. In: Biologicals Va, editor.Geneva: WHO, 2002.Available at http://www.who.int/immunization/diseases/rotavirus/generic_protocols/en/ (accessed 6 September 2015).
  • Simmonds MK, Armah G, Asmah R et al.New oligonucleotide primers for P-typing of rotavirus strains: strategies for typing previously untypeable strains. J Clin Virol 2008;42: 368–373.
  • Jiang X, Huang PW, Zhong WM et al.Design and evaluation of a primer pair that detects both Norwalk- and Sapporo-like caliciviruses by RT-PCR. J Virol Methods 1999;83: 145–154.
  • Ruuska T, Vesikari T.Rotavirus disease in Finnish children: use of numerical scores for clinical severity of diarrhoeal episodes. Scand J Infect Dis 1990;22: 259–267.
  • Bai ZS, Chen DM, Shen S. [Selection and characterization of strain LLR- 85 for oral rotavirus live vaccine.] Zhong Guo Sheng Wu Zhi Ping Xue Za Zi 1994;7: 46–52.Chinese.
  • Clark HF, Offit PA, Parashar UD et al.Rotavirus vaccines.In: Plotkin SA, Orenstein WA, Offit PA, editors. Vaccines, 5th edn.Atlanta: Elsevier Inc., 2008: 715–734.
  • Orenstein WA, Bernier RH, Dondero TJ et al.Field evaluation of vaccine efficacy. Bull World Health Organ 1985;63: 1055–1068.
  • Shapiro ED. Case-control studies of the effectiveness of vaccines: validity and assessment of potential bias. Pediatr Infect Dis J 2004;23: 127–131.
  • Schlesselman JJ. Case-control studies: design, conduct, analysis.New York: Oxford University Press, 1982.
  • Vesikari T, Isolauri E, D'Hondt E et al.Protection of infants against rotavirus diarrhoea by RIT 4237 attenuated bovine rotavirus strain vaccine. Lancet 1984;1: 977–981.
  • Parashar UD, Steele D, Neuzil K et al.Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium. Expert Rev Vaccines 2013;12: 113–117.
  • Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR et al.Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med 2006;354: 11–22.
  • Vesikari T, Matson DO, Dennehy P et al.Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med 2006;354: 23–33.
  • Bresee JS, Hummelman E, Nelson EA et al.Rotavirus in Asia: the value of surveillance for informing decisions about the introduction of new vaccines. J Infect Dis 2005;192: S1–S5.
  • Clemens J, Brenner R, Rao M et al.Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA 1996;275: 390–397.
  • Armah GE, Sow SO, Breiman RF et al.Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376: 606–614.
  • Zaman K, Dang DA, Victor JC et al.Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet 2010;376: 615–623.
  • Soares-Weiser K, Maclehose H, Bergman H et al.Vaccines for preventing rotavirus diarrhoea: vaccines in use. Cochrane Database Syst Rev 2012;11: CD008521.
  • Matson DO, O'Ryan ML, Pickering LK et al.Characterization of serum antibody responses to natural rotavirus infections in children by VP7-specific epitope-blocking assays. J Clin Microbiol 1992;30: 1056–1061.
  • Ward RL, Clemens JD, Knowlton DR et al.Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J Infect Dis 1992;166: 1251–1257.
  • Li Y, Wang SM, Zhen SS et al.Diversity of rotavirus strains causing diarrhea in <5 years old Chinese children: a systematic review. PLoS One 2014;9: e84699.
  • Smith PG, Rodrigues LC, Fine PE.Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. Int J Epidemiol 1984;13: 87–93.
  • Orenstein WA, Bernier RH, Hinman AR.Assessing vaccine efficacy in the field. Further observations. Epidemiol Rev 1988;10: 212–241.
  • Comstock GW.Evaluating vaccination effectiveness and vaccine efficacy by means of case-control studies. Epidemiol Rev 1994;16: 77–89.
  • Zheng JS, Cao L, Guo SC et al. [Survey on the immunization status of category B vaccine among children aged 1 to 2 years in China.] Zhong Guo Yi Miao He Mian Yi 2012;18: 233–237.Chinese.
  • Wang ZB, Wang W, Guo WS et al. [Survey on vaccination rate of second class vaccine and influencial factors in children in rural areas of nine counties in Henan province.] Wei Sheng Wu Xue Mian Yi Xue Jin Zhan 2013;41:53–61.Chinese.
  • Chang J, Hou ZY, Yue DH et al. [Factors related to self-paid vaccination and its related factors among children aged 0-3 years in China.] Zhong Guo Gong Gong Wei Sheng 2014;30: 579–582.Chinese.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.